Soulager Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-12-2024
- Paid Up Capital ₹ 0.10 M
as on 03-12-2024
- Company Age 8 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.50 M
as on 03-12-2024
- Revenue 4.76%
(FY 2020)
- Profit 8.57%
(FY 2020)
- Ebitda 1213.63%
(FY 2020)
- Net Worth 48.76%
(FY 2020)
- Total Assets 43.30%
(FY 2020)
About Soulager Healthcare
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.50 M.
Neha Soni and Yuvraj Soni serve as directors at the Company.
- CIN/LLPIN
U52609MP2016PTC041472
- Company No.
041472
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Sep 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Soulager Healthcare Private Limited offer?
Soulager Healthcare Private Limited offers a wide range of products and services, including Ayurvedic & Herbal Health Supplement, Herbal Supplements, Ayurvedic,Herbal Products & Medicine, Ayurvedic Herbal Syrups & Tonics, Ayurvedic & Herbal Extracts, Herbal Extracts, Chemical Reagents & Catalysts, Potassium Salts, Nutraceuticals & Dietary Supplements, Weight Loss Supplement.
Who are the key members and board of directors at Soulager Healthcare?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Neha Soni | Director | 03-Sep-2024 | Current |
Yuvraj Soni | Director | 14-Sep-2016 | Current |
Financial Performance of Soulager Healthcare.
Soulager Healthcare Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 4.76% increase. The company also saw a slight improvement in profitability, with a 8.57% increase in profit. The company's net worth Soared by an impressive increase of 48.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Soulager Healthcare?
In 2018, Soulager Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Lender | Amount | Status |
---|---|---|
State Bank Of India Creation Date: 13 Aug 2018 | ₹5.50 M | Open |
How Many Employees Work at Soulager Healthcare?
Unlock and access historical data on people associated with Soulager Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Soulager Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Soulager Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.